Table 4.
In vivo antioxidant and anti-glycation effects of rooibos, hibiscus, yerba mate extracts.
| Target Effect/Organ | Species [Extract] | Concentration | Animal Model | Measure | Effect | Tendency | Reference |
|---|---|---|---|---|---|---|---|
| Antioxidant/Brain |
A. linearis [Aqueous] |
1 g/100 mL | Immobilization-induced oxidative stress Sprague Dawley rats | CAT | Control (Stress): 2 unit/mg Extract: 3 unit/mg |
↑ | [143] |
| FFA | Control (Stress): 700 µg/mL Extract: 650 µg/mL |
↓ | |||||
| GSH/GSSG | Control (Stress): 7.5 Extract: 9 |
↑ | |||||
| HIAA | Control (Stress): 400 mg/g tissue Extract: 350 mg/g tissue |
↓ | |||||
| Lipid peroxidation | Control (Stress): 50 nmol/g tissue Extract: 40 nmol/g tissue |
↓ | |||||
| SOD | Control (Stress): 1 unit/mg Extract: 1.7 unit/mg |
↑ | |||||
|
H. rosa-sinensis [Aqueous] |
25 mg/kg body weight | STZ induced diabetic Male Sprague-Dawley | CAT | Control (Diabetic): 5 U/mg Extract: 10 U/mg |
↑ | [142] | |
| SOD | Control (Diabetic): 7 U/mg Extract: 15 U/mg |
↑ | |||||
|
H. sabdariffa [Aqueous] |
200 mg/kg body weight | Male Swiss albino mice | MDA | Control (STZ): 3 nmol/g White hibiscus extract: 0.5 nmol/g Red hibiscus extract: 0.5 nmol/g |
↓ | [25] | |
| MPO | Control (STZ): 75 µg/mg tissue White hibiscus extract: 20 µg/mg tissue Red hibiscus extract: 20 µg/mg tissue |
↓ | |||||
| Cox-2 | Control (STZ): 4 (fold change) White hibiscus extract: 1 (fold change) Red hibiscus extract: 1 (fold change) |
↓ | |||||
|
H. sabdariffa [Ethanolic] |
500 mg/kg body weight | Cypermethrin oxidative stress male mice (Mus musculus) | AChE | Control (Cypermethrin): 0.5 µmol/min/mg Extract: 2.5 µmol/min/mg |
↓ | [163] | |
| CAT | Control (Cypermethrin): 0.04 µmol/min/mg Extract: 0.06 µmol/min/mg |
↓ | |||||
| H2O2 | Control (Cypermethrin): 1.2 µmol/mg Extract: 0.3 µmol/mg |
↓ | |||||
| MDA | Control (Cypermethrin): 2 µmol/mg Extract: 0.5 µmol/mg |
↓ | |||||
|
I. paraguariensis [Aqueous] |
200 mg/mL | Chronic immobilization stress male Wistar rats | GSH/GSSG | Control: 0.48 Extract: 0.50 |
→ | [154] | |
| Lipid peroxidation | Control: 2.1 TBA/mg Extract: 1.3 TBA/mg |
↓ | |||||
| 200 mg/mL | Male Wistar rats | GSH/GSSG | Control: 4.7 Extract: 16.6 |
↑ | [153] | ||
| Lipid peroxidation | Control: 1.3 MDA eq/mg Extract: 0.3 MDA eq/mg |
↓ | |||||
| 50 mg/kg BW | PTZ-induced seizure male Wistar rats | CAT | Control (PTZ): 5 mmol/min/mg Extract: 9 mmol/min/mg |
↑ | [164] | ||
| SOD | Control (PTZ): 15.50 U/mg Extract: 23 U/mg |
↑ | |||||
| Sulfhydryl protein | Control (PTZ): 0.09 nmol DTNB/mg Extract: 0.31 nmol DTNB/mg |
↑ | |||||
| Anti-glycoxidation |
H. rosa-sinensis [Ethanolic] |
25 mg/kg BW | STZ induced diabetic Male Sprague-Dawley | Glycated hemoglobin | Control: 13% Extract: 6% |
↓ | [142] |
|
H. sabdariffa [Methanolic] |
200 mg/kg BW | STZ induced diabetic Male Sprague-Dawley | Serum glucose | Diabetic control: 400 mg/dL Extract: 100 mg/dL |
↓ | [162] | |
| AGE levels | Diabetic control: 4.5 mg/mL Extract: 3 mg/dL |
↓ |
STZ: streptozotocin.